Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Despite the pandemic maintaining its grip on the economy, 2022 will be another hot year for healthcare.

Global Leader, Health and Life Sciences, Oliver Wyman

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Former Engagement Manager, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Five Healthcare Predictions

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Global Leader, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Why closing the loop and creating a virtuous health promotion cycle will transform "sick care" to "well-care."

Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Overheard at the 2021 J.P. Morgan Healthcare Conference

The future of care delivery is changing quickly, as are new focuses for executives driving big change ahead.

Six Predictions for an Industry in Transformation

Welltok and Oliver Wyman discuss why this year is healthcare's watershed moment and what may unfold in 2021.

Chairman of the Board, Welltok
Global Leader, Health and Life Sciences, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.

CEO, Independent Grocers Alliance
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe